|本期目录/Table of Contents|

[1]叶俏.特发性肺纤维化与胃食管反流的研究进展[J].慢性病学杂志,2015,(01):39-43.
点击复制

特发性肺纤维化与胃食管反流的研究进展(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2015年01期
页码:
39-43
栏目:
综述
出版日期:
2015-01-29

文章信息/Info

Title:
-
作者:
叶俏
首都医科大学附属北京朝阳医院,职业病与中毒医学科,北京100020
Author(s):
-
关键词:
特发性肺纤维化胃食管反流肺损伤
Keywords:
-
分类号:
R563.9
DOI:
-
摘要:
特发性肺纤维化(IPF) 是一类慢性纤维化性肺疾病,隐匿起病,迅速进展,导致患者发生呼吸衰竭 和死亡。IPF 病因不清,其发病可能与易感基因、老龄、烟草暴露、环境因素、病毒、免疫失衡,以及慢 性胃肠道酸或非酸物质反流和吸入等因素有关。目前的假说认为,具有易感倾向的个体,尤其是老龄人群 反复慢性微吸入引起肺泡上皮细胞损伤和修复异常,导致肺成纤维细胞增殖和活化,胶原沉积和肺纤维化 形成。IPF 合并高发的胃食管反流为假说提供了依据。部分IPF 急性加重患者的支气管肺泡灌洗液中可以 检测到增高的胃蛋白酶,为胃液成分进入下呼吸道提供了直接的证据,提示慢性微吸入可能在IPF 急性加 重中起作用。药物或外科治疗胃食管反流可以使IPF 患者肺功能维持稳定,抗胃食管反流为IPF 的治疗提 供了新的靶点。目前,亟待进行前瞻性临床研究,观察干预胃食管反流对IPF 疾病病程的影响,进一步阐 明胃食管反流与IPF 病情进展的关系。
Abstract:
-

参考文献/References:

[1] Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis [J]. Am J Respir Crit Care Med, 2011,183(4):431-440.
[2] Olson AL, Swigris JJ, Lezotte DC, et al. Moratlity from pul? monary fibrosis increased in the United States from 1992 to 2003 [J]. Am J Respir Crit Care Med, 2007,176(3):277- 284.
[3] Ahluwalia N, Shea BS, Tager AM. New therapeutic targets in idiopathic pulmonary fibrosis: aiming to rein in runaway wound healing responses [J]. Am J Respir Crit Care Med, 2014,190(8):867-878.
[4] Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evi? dence- based guidelines for diagnosis and management [J]. Am J Respir Crit Care Med, 2011, 183(6): 788–824.
[5] 叶俏,代华平.特发性肺纤维化的治疗进展[J].国际呼吸杂志, 2012,32(11):455-60.
[6] Raghu G. Idiopahtic pulmonary fibrosis: increased survival with “ gastroesophageal reflux therapy ” - Fact or fallacy [J]. Am J Respir Care Med, 2011,184(12):1330-1332.
[7] Raghu G, Weycker D, Edelsberg J, et al. Incidence and preva lence of idiopathic pulmonary fibrosis [J]. Am J Respir Crit Care Med, 2006, 174(7):810-816.
[8] Selman M, Rojas M, Mora AL, et al. Aging and interstitial lung diseases: unraveling an old forgotten player in the patho? genesis of lung fibrosis [J]. Semin Respir Crit Care Med, 2010,31(5):607-617.
[9] Poh CH, Navarro-Rodrigues T, Fass R. Review: treatment of gastroesophageal reflux disease in the elderly [J]. Am J Med, 2010,123(6):496-501.
[10] Lee JS. The role of gastroesophageal reflux and microaspiration in idiopathic pulmonary fibrosis [J]. Clin Pulm Med, 2014, 21(2):81-85.
[11] Allaix ME, Fisichella PM, Noth I, et al. Idiopathic pulmonary fibrosis and gastroesophageal reflux [J].Gastrointest Surg, 2014, 18(1):100-4.
[12] Morehead RS. Gastro- oesophageal reflux disease and nonasthma lung disease [J]. Eur Respir Rev, 2009,18(114): 233-243.
[13] Stovold R, Forrest IA, Corris PA, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection [J]. Am J Respir Crit Care Med, 2007,175 (12):1298–1303.
[14] Amigoni M, Bellani G, Scanziani M, et al. Lung injury and re? covery in a murine model of unilateral acid aspiration: function? al, biochemical, and morphologic characterization [J]. An? esthesiology, 2008,108(6):1037-1046.
[15] Appel III JZ, Lee SM, Hartwig MG, et al. Characterization of the innate immune response to chronic aspiration in a novel ro? dent model [J]. Respir Research, 2007, 27(8):87-99.
[16] Perng DW, Chang KT, Su KC, et al. Exposure of airway epi? thelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 pro? duction and fibroblast proliferation [J].Chest, 2007, 132(5): 1548-1556.
[17] Havemann BD, Henderson CA, El- Serag HB. The associa? tion between gastroesophageal reflux disease and asthma: a sys? tematic review [J]. Gut, 2007,56(12): 1654-1664.
[18] Barnes TW, Vassello R, Tazelaar HD, et al. Diffuse bronchi? olar disease due to chronic occult aspiration [J]. Mayo Clin Proc,2006, 81(2): 172-176.
[19] Friedlander AL, Fessler MB. A 70-year-old man with migra? tory pulmonary infiltrates [J]. Chest, 2006, 130(4): 1269- 1274.
[20] Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticoste? roids increase esophageal acid contact times in patients with sta? ble asthma [J]. Chest, 2002, 121(2): 625-634.
[21] Savarino E, Bazzica M, Zentilin P, et al. Gastro- esophageal reflux and pulmonary fibrosis in scleroderma: a study using pHimpedance monitoring [J]. Am J Respir Crit Care Med, 2009, 179(5):408-413.
[22] Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastroo? esophageal reflux and gastric aspiration in lung transplant pa? tients with or without chronic rejection [J]. Eur Respir J, 2008, 31(4):707-713.
[23] Tobin RW, Pope CE, Pellegrini CA, et al. Increased preva? lence of gastroesophageal reflux in patients with idiopathic pul? monary fibrosis [J]. Am J Respir Crit Care Med, 1998,158 (6) :1804-1808.
[24] Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro- oesophageal reflux in idiopathic pul? monary fibrosis [J].Eur Respir J, 2006, 27(1): 136-142.
[25] Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal re? flux in patients with idiopathic pulmonary fibrosis referred for lung transplantation [J]. J Thorac Cardiocasc Surg, 2007, 133(4):1078-1084.
[26] Noth I, Zangan SM, Soares RV, et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis [J].Eur Respir J, 2012,39(2):344-351.
[27] Lee JS, Song JW, Wolters PJ, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis [J]. Eur Respir J, 2012,39(2):352-358.
[28] Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series [J]. Chest, 2006,129(3):794-800.
[29] Linden PA, Gilbert RJ, Yeap BY, et al. Laparoscopic fundo? plication in patients with end-stage lung disease awaiting trans? plantation [J].J Thorac Cardiovasc Surg, 2006,131(2):438- 446.
[30] Kilduff CE, Counter MJ, Thomas GA, et al. Effect Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study [J]. Cough, 2014,10(4):4.
[31] Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in idiopathic pulmo? nary fibrosis [J]. Am J Respir Crit Care Med, 2011, 184 (12):1390-1394.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金面上项目(81370159);北 京自然科学基金面上项目(7142058) 作者简介:叶俏,博士,主任医师,主要从事呼吸系统 病的研究工作 通信作者:叶俏,E-mail: birmyeqiao@sina.com
更新日期/Last Update: 2015-01-15